27 December 2022
Cyril Amarchand Mangaldas advises Jefferies on INR 650 crore block trade in Ajanta Pharma shares
Advising firms
Deal team
3 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Vijay Parthasarathi Lead | Cyril Amarchand Mangaldas | Partner | Capital Market | Not stated |
| Aashima Johur | Cyril Amarchand Mangaldas | Other | Capital Market | Not stated |
| Kinjal Shah | Cyril Amarchand Mangaldas | Senior associate | Capital Market | Not stated |
Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- INR 6.50bn (INR 650 crore)
- What the figure measures
- Total transaction value
- Client
- Jefferies India Private LimitedOther
- Counterparties
- Ravi Agrawal Trust (Sell-side)
Aayush Agrawal Trust (Sell-side)
Ajanta Pharma Limited (Other)